Tadimax
824 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Pharmacotherapeutic group: A means of treating benign prostatic hyperplasia of plant origin.
Pharmacological properties: The drug has anti-inflammatory, analgesic, moderate angioprotective effect.
Indications
In complex therapy to eliminate dysuric disorders, with benign prostatic hyperplasia of stage I and II.
Composition
Active substances: 371.3 mg of thick aqueous extract (14.5: 1) from the mixture: Cinnamon leaves 2 g, Anemarins of rhizomes 0.666 g, Velvet bark 0.666 g, Hermitage 0.666 g, Peach seeds 0.083 g, Alismatis rhizomes 0.830 g, Peony roots 0,500 g, Brownberry bark 0,0083 g
excipients: colloidal silica, starch, magnesium stearate, hypromellose, talc, macrogol dioxide titanium 6000, red iron oxide (E 172), black iron oxide (E 172).
No customer reviews for the moment.
Dosage and Administration
Inside 2 pills 3 times a day after meals. The drug should be taken as follows: 3 courses of 7 days of admission with breaks between courses of 7 days. The duration of treatment is determined by the doctor.
Adverse reactions
Allergic reactions are possible. In 5% of cases at the beginning of the drug in patients may experience a burning sensation in the anus. This phenomenon takes place in the process of taking the drug.
Contraindications
Hypersensitivity to the components of the drug, severe violations of the liver.
Special instructions
Before use, it is recommended to consult a doctor.
- Active ingredient: Tadimax
8 other products in the same category:
arrow_upward